The satisfaction of dipping a knife into a jar of creamy peanut butter to pair with apple slices or a slice of toast is quite reasonably one of the better things in life. Sadly, not everyone is able to enjoy this simple luxury—until now.
Peanut allergies are widely spread throughout the Western world among children and adults, affecting about 2% of American children, and they pose serious health risks.
Thanks to a drug developed by a French biopharmaceutical company, the worry of having a peanut allergy flare-up may soon become nonexistent. The product is similar to a Nicotine patch and it significantly increases users' peanut tolerance, according to CNN Money.
The company, DBV Technologies, is hoping to sell the product to Americans as early as the beginning of 2018. The Food and Drug Administration has fast-tracked its testing approval, and it's already set to begin Phase III trials by the end of the year.
Whether those using the patch can pop open some peanut shells and toss them into their mouth like it's nothing is unclear, but at least the risk of having an allergy attack will be lowered with the patch's use. And for those who have experienced such attacks, that's probably enough of a reason to slap one on every day.
[via WLKY.com]
